ロード中...
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
Since 1975, 191 patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (ChlVPP). Complete remission rates were 73% for previously untreated patients, 91% for patients previously treated with radiotherapy and 55% for patie...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1982
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2011032/ https://ncbi.nlm.nih.gov/pubmed/7093120 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|